Dekio I, Katsuta M, Ishiuji Y, Nobeyama Y, et al. Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023). J Dermatol 2025 Sep 8. doi: 10.1111/1346-8138.17927.
PMID: 40916993